Needham & Company reiterates a 'Buy' on Vivus (NASDAQ: VVUS), PT $15.

Needham analyst says, "Vivus submitted a Qnexa Briefing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE